Literature DB >> 21120116

Is there evidence for effectiveness of acamprosate in maintaining abstinence in alcohol dependent patients?

Biju Basil1, Mathews Thomas, Indranil Chakrabarti, Vinu George, Maju Mathews, Babatunde Adetunji.   

Abstract

Entities:  

Year:  2005        PMID: 21120116      PMCID: PMC2994241     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


× No keyword cloud information.
  12 in total

1.  The long-term cost-effectiveness of improving alcohol abstinence with adjuvant acamprosate.

Authors:  A J Palmer; K Neeser; C Weiss; A Brandt; S Comte; M Fox
Journal:  Alcohol Alcohol       Date:  2000 Sep-Oct       Impact factor: 2.826

2.  Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence.

Authors:  H Sass; M Soyka; K Mann; W Zieglgänsberger
Journal:  Arch Gen Psychiatry       Date:  1996-08

3.  Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study.

Authors:  I Pelc; P Verbanck; O Le Bon; M Gavrilovic; K Lion; P Lehert
Journal:  Br J Psychiatry       Date:  1997-07       Impact factor: 9.319

Review 4.  Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action.

Authors:  Philippe De Witte; John Littleton; Philippe Parot; George Koob
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Clinical characterization of use of acamprosate and naltrexone: data from an addiction center in India.

Authors:  Debasish Basu; Om Prakash Jhirwal; Surendra K Mattoo
Journal:  Am J Addict       Date:  2005 Jul-Sep

6.  Pharmacological treatment of alcohol dependence: a review of the evidence.

Authors:  J C Garbutt; S L West; T S Carey; K N Lohr; F T Crews
Journal:  JAMA       Date:  1999-04-14       Impact factor: 56.272

7.  Effect of community nurse follow-up when treating alcohol dependence with acamprosate.

Authors:  I Pelc; C Hanak; I Baert; C Houtain; P Lehert; F Landron; P Verbanck
Journal:  Alcohol Alcohol       Date:  2005-05-03       Impact factor: 2.826

8.  Cost-effectiveness of adjuvant treatment with acamprosate in maintaining abstinence in alcohol dependent patients.

Authors:  R Rychlik; H Siedentop; T Pfeil; D Daniel
Journal:  Eur Addict Res       Date:  2003-04       Impact factor: 3.015

9.  The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis.

Authors:  Karl Mann; Philippe Lehert; Marsha Y Morgan
Journal:  Alcohol Clin Exp Res       Date:  2004-01       Impact factor: 3.455

10.  Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol.

Authors:  F M Paille; J D Guelfi; A C Perkins; R J Royer; L Steru; P Parot
Journal:  Alcohol Alcohol       Date:  1995-03       Impact factor: 2.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.